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Twenty years ago this July in
Seveso, Italy, a reaction vessel in
a chemical factory exploded,
spewing a foul-smelling com-
pound that caused birds to fall
from the sky. Over the next
month, 200 residents developed
chloracne, indicating exposure to
dioxin, says Neil Caporaso, a sci-
entist in the Genetic Epidemi-
ology Branch of the National
Cancer Institute. All farm ani-
mals were slaughtered and the
town was divided up into several
zones based on level ofexposure.
In the most heavily exposed dis-
tricts, the soil was dug up and
carted away, and houses were
razed. Fortunately, blood sam-
ples of residents had been
banked, for although only the
highest exposures could be mea-
sured at the time, now "we can
classify the exposures that literal-
ly hundreds of people had, and
tell what areas were hit," says
James Pirkle, assistant director for science
in the Division of Environmental Health
Laboratory Sciences of the Centers for
Disease Control (CDC). "Some areas were
declared safe that actuallywere hit."
Studies based on these samples are
beginning to reveal the relationship of
dioxin exposure to various cancers, and
researchers have been able to go back to
exposed individuals and find out how
strongly the compound has persisted in
their bodies. "Much ofour understanding
about the persistence ofdioxin in humans
depends on this," says Caporaso.
"Banked specimens present a great
resource for evaluating environmental and
occupational health problems," says Paul
A. Schulte, acting director of the
Education and Information Division ofthe
National Institute for Occupational Safety
and Health. "Human tissue samples really
[provide] a measure ofdose," explains Ken
Sexton, professor of environmental health
at the University of Minnesota School of
Public Health.
The Holy Grail oftissue banking is to
relate levels of environmental contamina-
tion to health outcomes via doses-the
main pieces of information one looks for
in banked samples, says Jack A. Taylor,
head of the Molecular and Genetic
Epidemiology Group at the NIEHS.
Unfortunately, samples are
often banked without informa-
tion on exposures, and cohorts
are often not followed because
it is difficult and expensive to
do. Nonetheless, there is plenty
of value in more narrowly
designed studies.
Lately, a controversy over
informed consent has flared,
threatening to force researchers
to obtain new consent from
every individual in a cohort
study every time something new
is done with the banked materi-
als. The issue "terrorizes me,"
says Taylor.
The controversy is particu-
larly threatening to researchers
who use tissue banks in one of
their newest applications:
research on the genetics of sus-
ceptibility to specific carcino-
gens. "If we don't solve this
dilemma, no prospective cohort
that we design now will be
usable," says John Groopman, professor
and chairperson of the Department of
Environmental Health Sciences at the
Johns Hopkins University School of
Hygiene and Public Health ofthe issue of
consent.
National Monitoring
The monitoring of exposures to dioxin at
Seveso represents a quick response to an
acute and obvious problem. There is also a
need to track chemical contamination of
human tissues on a more ongoing basis,
according to the National Research
Council (NRC). In the United States,
more than 60,000 chemicals were
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approved for commercial use in 1984. Of
3,400 pesticide ingredients, only about
10% had data available for a complete
health hazard assessment, and more than
700 organic chemicals have been identified
in U.S. drinking water.
Several federal programs have experi-
mented with population-based monitoring
of human tissue samples. The National
Human Adipose Tissue Survey (NHATS),
an EPA program, scrutinized mainly pesti-
cide residues from 1967 to 1989, collect-
ing about 12,000 tissue samples, mostly
from cadavers. But NHATS was cited by
the NRC for quality control and other
problems and is virtually defunct. The
National Health and Nutrition
Examination Surveys (NHANES) of the
National Center for Health Statistics col-
lects blood periodically from a population-
based sample of about 20,000 U.S. citi-
zens, but the focus is mostly on nutrition.
Recently, several agencies including the
EPA and the CDC have established a pilot
population-based survey, the National
Human Exposure Assessment Survey
(NHEXAS), to monitor blood (50 ml per
subject), urine, hair, and in some cases,
fingernail, samples while also sampling the
air, water, soil, food, and dust from inside
the houses ofsubjects, says Sexton, who is
helping to run the program. Subjects will
answer a questionnaire concerning age,
gender, occupation, type of housing, and
indoor exposures to toxins from sources
such as gas stoves and cigarettes. The sur-
vey will be conducted on 50 people in the
Baltimore metropolitan area, 300-400
people in Arizona, and about 500 people
in EPA Region 5 (which includes Indiana,
Illinois, Michigan, Minnesota, Ohio, and
Wisconsin), says Sexton. Each pilot area is
run by a consortium of scientists who will
choose what to sample from among met-
als, volatile organics, pesticides and PAHs.
The same compounds will be sampled in
human subjects and the environment.
According to JerryAkland, project offi-
cer for NHEXAS, the project's success will
be measured by how much the additional
information reduces uncertainty in current
exposure models. In other words, if the
distribution of exposures is different from
what current models predict, it will justify
the cost ofa national survey. Such a survey
ofabout 5,000 people would be conducted
with subjects selected through statistically-
based sampling design. "This will give a
pretty good sense ofaverage exposures, and
... over time, you can see the trends," says
Sexton. "Almost without exception, we
don't have that kind ofinformation in this
country.
WhatTissue Banking Can Tell Us
Despite the lack of a direct link of expo-
sures to adverse health outcomes, a nation-
al monitoring study could be critically
important. The data could "help identify
new or previously unrecognized hazards ...
[and] establish trends in body burdens of
toxicants that result from changes in man-
ufacture, use, and disposal patterns, and
thus monitor the results of programs
intended to control specific chemical haz-
ards," according to the NRC's 1991 study,
Monitoring Human Tissues for Toxic
Substances.
For example, roughly five years after
the pesticide Mirex was used to kill fire
ants, retrospective analysis of NHATS tis-
sues from the period when it was used
found contamination in human tissues.
"Evidence of Mirex exposure . . . led to a
more intensive survey ofthe general popu-
lation in treated counties ofthe southeast-
ern United States," according to a 1985
article in the Journal of Toxicology and
EnvironmentalHealth.
Nationwide surveys are too broad to
furnish definitive data on health effects,
says John C. Bailar, III, chairperson ofthe
Department of Health Studies at the
University of Chicago. But they are very
important for estimating body burdens
and, hence, population-wide risk, as well as
for tracking the success of control pro-
grams, he said.
Furthermore, they provide a frame-
work for designing epidemiological studies,
once they have raised suspicions, says
David Kalman, a professor in the
Department of Environmental Health at
the University of Washington in Seattle.
"Knowing in advance the patterns in
prevalence [of a problem] gives clues as to
how to construct the study."
Studies where subjects are followed
after specimens are banked can furnish a
clearer picture ofhow specific compounds
University School of Hygiene and Public
Health has been conducting studies using
banked samples for two decades. In 1974
and again in 1989, over 25,000 blood sam-
ples were banked at the Washington
County (Maryland) blood bank.
Helzlsouer is comparing the level of
organochlorines in blood samples from
400 women who have since developed
breast cancer with samples from matched
controls, although there are no results yet.
She is also planning a similar investigation
of cadmium in the etiology of a similar
number ofcases ofprostate cancer.
In similar case-controlled studies of
serum and urine samples banked since the
early 1980s from cohorts in China and
Africa, Groopman and his collaborators
discovered "a strong interactive effect
between aflatoxin exposure and hepatitis B
virus exposure in the development ofliver
cancer." Supporting the hypothesis that
aflatoxin had influenced development of
cancer, mutations found in the p53 tumor
suppressor gene in these samples were
characteristic of types that form uniquely
in response to aflatoxin.
Attention has been focused on recent
discoveries of genes such as BRCA1 and
HNPCC-mutations that are associated
with a very high risk of breast and colon
cancer, respectively. Researchers have also
begun to discover genes that have far more
subtle relationships with cancer. For exam-
ple, "smoking is associated with increased
risk of lung, bladder, and other cancers,"
says Taylor. The protein product of the
gene, glutathione-S-transferase MBA
(GSTMJ), binds certain carcinogens, ren-
dering them easier to excrete into the
urine. But, Taylor says, "50% of
Caucasians, roughly, are walking around
with no working copy of that gene....
Within two groups who smoke the same
amount, the people without the detoxifica-
tion pathway are at about twice the risk of
Human tissue samples provide
a measure of dose. Ken Sexton
influence human health. Once disease has
set in, researchers can search the premorbid
materials for chemical, biochemical,
immunological, and other changes that
might predict development of cancer or
other diseases.
Kathy J. Helzlsouer, an associate pro-
fessor of epidemiology in the Department
of Epidemiology in the Johns Hopkins
developing cancer as those with a working
copy." Taylor and his colleagues are look-
ing at a whole series ofadditional genes to
try to identify the genetic and environmen-
tal determinants of bladder cancer. "We
continue to use banked samples and
detailed exposure information from the
same cases to try to put the genes and
exposures together," he said.
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In another similarly constructed study
using blood samples from the prospective
Harvard University Physicians Study,
Frederica Perera, a professor of public
health in the Division of Environmental
Health Sciences at the Columbia Uni-
versity School of Public Health, is investi-
gating the interaction of markers such as
polyaromatic hydrocarbon adducts on
albumin and DNA with genes controlling
metabolism ofcarcinogens in the develop-
ment ofcancer.
In addition to determining causal agents
for specific cancers, researchers can use
banked tissues to investigate the molecular
pathways by which specific pollutants
cause cancer. Several decades ago, Geno
Saccomanno, a pathologist at St. Mary's
Hospital in Grand Junction, Colorado,
noticed that lung cancer was common
among uranium miners, who breathe large
quantities of radon. Saccomanno began
storing blocks of resected lung tumors.
Taylor wondered whether the miners'
tumors might have different patterns of
genetic damage from those of smokers.
Examining 52 large and squamous cell
cancers from miners, he found that 31%
had an identical mutation in the p53
tumor suppressor gene, but that this muta-
tion was extremely rare in smoking-associ-
ated tumors.
Asbestos-associated lung cancers have
yet another pattern of mutation. Using a
structure, to measure particulates, and pos-
sibly to perform other histochemistry and
biochemistry studies, says Richard
Everson, a medical officerwith the PHS.
Taylor praised the study's thorough
collection ofexposure data, which includes
full residential histories of subjects linked
to zip code-related pollution measurements
taken by the California Air Resources
Board, as well as smoking, work-related
exposures, and even physical activity levels
ofsubjects.
What to Collect
Organ tissues are unusual in banking stud-
ies. Ninety-five percent of materials col-
lected for storage are blood and urine. The
reasons are simple. First, it is easy to do
cohort studies, because people are used to
having both types of samples taken under
normal circumstances, says Helzlsouer.
The question ofwhat type ofsample to use
as a control becomes more complicated
with, for example, surgical specimens of
cancer. "Do you use benign disease such as
breast lumps?" asks Helzlsouer.
"We recommend blood [as a standard
specimen] because it is readily accessible,
and not likely to be contaminated the way
hair and nails are," says Bailar. "People
wash their hair in all kinds offunny things,
and they get all kinds of funny stuff on
their hands." DNA can be obtained direct-
ly from blood and analyzed using PCR, or
The Holy Grail of tissue banking
is to relate levels of environmental
contamination to health outcomes
via doses. Jack Taylor
bank of asbestos-associated lung tumors
from the Telemark Central Hospital in
Norway, Taylor and his colleagues con-
ducted studies, presented at the Meeting of
the American Association of Cancer
Research in April 1996, showing patterns
ofbase-pair changes that are different from
the guanine (G) to thymine (T) mutations
that predominate in smoking-associated
tumors. Identifying exposure-specific
mutations could lead to development of
screens for early detection of cancers,
and-in the somewhat distant future-to
developing chemotherapies, says Taylor.
Different tissues can provide a variety
of other insights into the effects of pollu-
tion; The U.S. Public Health Service is
banking lung specimens from relatively
young accident victims in Los Angeles and
two control cities, Miami and Seattle, to
investigate the effects of ozone on tissue
white blood cells can be immortalized and
frozen in liquid nitrogen for future thaw-
ing and expanding.
Even fat can be obtained from blood
for sampling of fat-soluble contaminants
such as PCBs and pesticides. "There is a
very small lipid fraction in the white blood
cell that is in equilibrium with whatever is
in the blood stream," says Bailar. "The fat
fraction of blood should have about the
same concentration as any other body fat.
Our committee [Committee on National
Monitoring of Human Tissues of the
National Research Council] did recom-
mend that EPA undertake studies to vali-
date this." Furthermore, "new develop-
ments in analytic chemistry over maybe
the last 15 years can take this tiny fraction
and give you adequate readings of unbe-
lievable sensitivity," says Bailar. Others say
that sampling of fat-soluble contaminants
can be done still more easily and just as
accurately from blood lipids.
Easier than drawing blood is buccal
swabs, says Taylor. "It's nothing but a ster-
ile Q-tip. You have the person rub it on
the inside oftheir cheek." In a study inves-
tigating contribution of environment and
genotype to etiology ofcleft lip and palate
in Norway, Taylor's colleagues are using
buccal swabs to collect samples from con-
trols and from family members. "If we
tried to stick a needle into every person
that we wanted to get DNA samples from,
we would never get close to the participa-
tion rates that we can get with buccal
swabs," he says. Nonetheless, "blood is still
the gold standard because it gives you a lot
ofDNA that's veryhigh quality."
Urine is also a source of DNA,
"because cells are sloughed off from the
bladder," says Taylor. "In fact, for bladder
cancer, there's increasing interest in using
new techniques to look at the DNA of
sloughed cells to see ifwe can detect cancer
earlier than using traditional screening
techniques."
Some materials are much harder to col-
lect than blood and urine, but may offer
unique advantages. By virtue ofits biologi-
cal function, the liver accumulates pollu-
tants, but livers can be obtained only from
cadavers or surgical specimens. The
National Institute of Standards and
Technology (NIST) examined how feasible
it would be to collect livers from individu-
als who had been normal and healthy at
death, and determined that it was feasible,
especially from victims ofaccidents or gun-
shots, says Stephen Wise, a research
chemist at NIST. Wise was able to collect
300 livers in a single year. According to
Wise, lesson number one is that "you need
the cooperation ofthe medical examiner. If
the medical examiner is not interested in
getting you samples, you won't get any."
Ofcourse, samples that are collected from
cadavers are inherently biased. "Accident
victims don't have the same range of ages
and sex as the general population," says
Bailar. "They may differ in other ways,
too.
Whatever the tissue, researchers should
collect it with an eye toward the needs of
future investigators, says Taylor. He
should know; he has spent years doing
research with old samples of cancers from
the pathology departments ofhospitals. In
one study, Taylor says, "I had to go to hos-
pitals all over the country to track down
tumors and contact individual pathologists
and say, 'Can you find this 30-year-old
block?"' Samples are normally fixed in for-
malin and then embedded in paraffin
blocks for storage.
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Old blocks in particular often get hid-
den in the deepest, darkest corners ofa hos-
pital, so retrieving them is no easy task.
"We've had them all melted together in a
giant blob, or destroyed by fire, so you
can't always get what you want," Taylor
Saturday night and Sunday," Riboli said.
In the course of a major project con-
ducted by IARC, the European Prospective
Investigation into Cancer and Nutrition,
samples from 350,000 subjects are being
banked. The program is hailed as a model
If we don't solve the dilemma
of consent, no prospective
cohort we design now will
be usable. John Groopman
said. "Getting the pathologist to give up the
blocks is often tricky. You have to be care-
ful to return the blocks to the pathologist,
something I tryhard to do as fast as I can."
Storing and Maintaining Collections
Storage is the key to longevity ofsamples,
and there are many ways to do it. The best
method of storage is to freeze them in liq-
uid nitrogen at temperatures of -180'C to
-196°C. "The main reason you would
want to use liquid nitrogen is if you are
working with any cellular component
where you want all metabolic processes to
stop dead, and be able to revive the cell,"
says Elaine Gunter, chiefofthe NHANES
laboratory at the CDC. "Also, ifyou have
a cell that has an infectious agent that you
aren't aware of, it keeps the agent from
killing the cell." Additionally, liquid nitro-
gen also prevents the condensation and
desiccation that can plague a mechanical
freezer, says Gunter. Kalman refers to
freezing in liquid nitrogen as a "suspenders
and belt" approach that offers the best pro-
tection in view ofuncertainty about future
investigations ofstored samples.
On the other hand, ifthe goal is simply
to be able to identify environmental pollu-
tants in tissues at some later date, fairly
high temperatures and even room tempera-
tures can be adequate to preserve many of
the more common pollutants, such as
heavy metals and aromatic hydrocarbons,
says Kalman.
For successful long-term freezing, liq-
uid nitrogen is also more ofa fail-safe than
mechanical freezing, says Elio Riboli, chief
ofthe Unit ofNutrition and Cancer at the
International Agency for Research on
Cancer (IARC). Pressure differences drive
replenishment of the storage containers
from a large reservoir of liquid nitrogen,
which can stay cold enough to maintain
the storage containers for two months
without electricity. "I have had samples
stored [in mechanical freezers] at -80°C,
but we have all had the experience of the
freezer breaking down, usually between
of excellent storage techniques. To avoid
having to thaw and refreeze samples every
time an analysis is needed, "plasma, serum,
buffy coat, and red blood cells will be
stored in small plastic straws with a capacity
of only 0.5 ml," according to IARC, with
30 ml being collected from each subject.
Pre-labeled jackets in a different color
for each of the four blood fractions stored
fit tightly around each straw. For insur-
ance, the 28 straws for each subject are
divided into identical series of 14, one
stored at the center where the blood is col-
lected, and the other at IARC. IARC has
developed a system for organizing the sam-
ples for quick, easy access. "The large
capacity [of liquid nitrogen systems lends
itselfl to a very organized storage system,"
says Gunter, "so you can set up a comput-
erized inventory and track by rack, box,
position, tray, or whatever."
The CDC has about 500 mechanical
freezers storing materials at -70'C, says
Gunter. "It's easier where you are going in
and out every day." But the CDC is reno-
vating a facility of 220 large-capacity, liq-
uid-nitrogen freezers, large enough to store
"literally millions ofsamples," says Gunter.
As for storage requirements of other
materials, the 25,000 samples ofsera from
the Washington County Blood Bank are
are "pretty stable," says Taylor. "That's the
longest we've looked." As for urine,
longevity hasn't been established, says
Taylor, who freezes most ofthe samples he
collects at -20°C. "I'mjustwinging it."
NHATS provided some examples of
how not to store samples, according to the
NRC. Specimens stored in glass bottles
sealed with metal caps with foil-lined card-
board inserts had rusty caps, and 10-15%
of the specimens contained pieces of foil.
Some caps were loose, and specimens had
dried out. "Storage artifacts . . . become
severe after five to six years ofstorage," the
report concluded.
Informed Consent
Almost ten years have passed since the
National Center for Environmental Health
(NCEH) of the CDC decided to create a
DNA bank from NHANES blood. At the
time, says Karen Steinberg, chief of the
Molecular Biology Branch of the NCEH,
"there weren't a lot ofthings to test for. All
the issues apparent today were not appar-
ent then." But as new gene discoveries
began to occur on practically a weekly
basis, Steinberg began to worry. "We did-
n't feel our consent was sufficient to do
linked testing," she says.
Groopman says that the debate two
years ago over health care reform as it relat-
ed to preexisting conditions further high-
lighted the issue of consent. Steinberg is
more worried that subjects in research on
one gene, who have said they want the
results, might be presented by well-mean-
ing researchers with information concern-
ing genes not covered in consent forms,
such as breast cancer or colon cancer genes.
These concerns led to a meeting spon-
sored jointly by the National Center for
Human Genome Research and the CDC
of medical ethicists, lawyers, and
researchers from around the country, and
to an article in the 13 December 1995
Nationwide surveys are important
for estimating population-wide
risks and for tracking the success
of toxin control programs.
John C. Bailar, III
stored at -70'C in mechanical freezers over
20 years old, says Helzlsouer. "We still get
levels of nutrients and hormones that we
would expect, so we think they are fairly
stable."
So far, for periods ofat least three years,
at temperatures of-20'C and -70'C and in
alcohol at room temperature, buccal swabs
issue oftheJournaloftheAmericanMedical
Association (JAMA) by Steinberg and sever-
al co-authors. The article advocated poli-
cies that some researchers consider to be
dangerously restrictive, creating quite a
controversy. Such policies include a
requirement that it be impossible for any-
one, including the principal investigator,
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Name ofstudy No. ofsamples Type ofsample Endpoint
National Human Adipose Tissue Survey (NHATS) 12,000 fattissues pesticide residues
National Health and Nutrition Examination Surveys (NHANES) 20,000 blood mostly nutrition
National Human Exposure Assessment Survey (NHEXAS) about950 blood, urine, hair, fingernail metals, volatile organics,
pesticides, PAHs
Breast and prostate cancer studies (Helzlsouer) 25,000 blood organochlorines and breast
cancer, cadmium and
prostate cancer
Harvard University Physicians Study 15,000 blood PAH biomarkers, gene metabolism
and carcinogens
Uranium miner studies (Taylor) 52 squamous cell cancers mutation in the p53tumor
suppressor gene
Lung cancer study (Taylor) 25 asbestos-associated mutations in smoking-associated
lung tumors tumors
Aflatoxin and liver cancer study (Groopman) 18,000 serum and urine interaction between aflatoxin and
hepatitis B in liver cancer
to link human specimens with individuals,
or that a new informed consent must be
obtained every time a researcher studies a
new gene.
In their rush to protect research sub-
jects, says Caporaso, Steinberg and others
are confusing the big risks to individuals of
having a BRCAI breast cancer gene or
HNPCCcolon cancer gene with risks from
metabolic polymorphisms that are insignifi-
cant from the standpoint ofthe individual,
yet important to public health. "It would
be farfetched to think that [genes for car-
cinogen-metabolizing proteins] would have
health implications for families," says
Everson. But the proposed standards would
hamstring this research, says Schulte.
The standard ofanonymity is impossi-
ble to achieve without dumbing informa-
tion on each individual down to useless-
ness, some researchers say. It only takes a
few pieces of information such as grade
and stage of tumor, age at resection, race,
and smoking habit to make possible a
definitive identity, even if all links in the
database have been cut. "As an example of
anonymity," says Steinberg, " a set ofsuch
parameters should identify at least three
people.
"Requiring consent for every new gene
to be studied from a sample is untenable,"
asserts Caporaso, "in that it does not appear
to serve either the individual's interest or
those of science. The cost is prohibitive. If
it's a population-based cohort . .. and you
want to write to every person and saywe are
going to test a genetic marker, this is what it
means: with a cohort of100,000 people, the
cost is conservatively in the millions."
But in dealing with human subjects, it
is important to err on the side of caution,
Steinberg asserts, alluding to the medical
establishment's past paternalism. "We are
the servants of the public. We have to be
very sensitive to issues ofimportance to the
public . . . and we have to deal with their
perception ofrisk."
The JAMA authors also recommended
"enactment of more general legislation to
ensure that no person or institution be able
to obtain access, even by court order or
subpoena, to either the samples used in
research or the specific results of research
performed on such samples." Their reason-
ing was that "although protection may
already be provided by certificates ofconfi-
dentiality, sources are entitled to this high-
er level of protection in exchange for
allowing their samples to be used for
research."
The Office for Protection from
Research Risks at NIH might develop its
own guidance, and the new National
Bioethics Advisory Commission being
established by President Clinton could
issue guidance, says John Miller, the
office's deputy director. For the moment at
least, such guidance remains the province
ofindividual institutional review boards.
The controversy over informed consent
has left those who bank on tissues holding
their breath. Tissue banking has proven its
value as a versatile method ofstudying the
impact ofenvironmental contamination on
human health, and for contributing infor-
mation for environmental policy-making.
Questions such as deciding how to con-
duct a study, which tissues to collect, and
how best to store them can be difficult to
answer, but usually yield to creativity, hard
work, and money. Researchers fear that
current issues surrounding informed con-
sent might not be nearly so tractable. How
this controversy plays out will have a pro-
found impact on a crucial area ofenviron-
mental research.
David Holzman
ERRATA
The second paragraph of the second
column on page 23 of the article The
Attack ofAsthma in the January 1996
issue ofEHP(104:1) mistakenly attrib-
utes statisics about Puerto Rican chil-
dren and asthma to the New York
Times. The information is taken from
an article that appeared in the April
1993 issue of the AmercanJurnal of
Public alh (83:4), nti Reported
Asthma amon Puerto Rican, Mexican-
American, and Cuban Children, 1982
through 1984. The statistics were also
incorretl identified as the rates of
asthma among Puerto Rican, Mexican
American, Cuban, black, and white
chide betwen 1982 aindl9. Th
should have been identified as the per
centaeof childii who have eve h
asthma. Als in t ais E ed, the
date at the bottonLo the ;i WtcIn
on pg 23 mistakly ir ce
1976 And 1908." Th4eteehould
read "1980."
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